Literature DB >> 8257960

Slow replenishment of carnitine deficiency after cessation of long-term treatment with pivaloyl-containing antibiotics.

Q N Diep1, T Bøhmer, J I Holme, A Torvik, O T Storrøsten, C W Loennecken, P Monstad, E Jellum.   

Abstract

Long-term treatment with pivampicillin and pivmecillinam for 6-24 months in five adults and one child reduced the total serum carnitine concentration to 3.7-14 mumol/l (reference value: 25-66 mumol/l). Muscle carnitine was reduced to 0.3-0.7 mumol/g wet weight (reference value: 3-5 mumol/g) in two cases. All patients had muscle symptoms with weakness, asthenia and pains. One showed signs of carnitine depletion in the liver with increased secretion of dicarboxylic acids (C6, C8, C10) in urine and limited ketone body formation during prolonged fasting. Serum carnitine increased slowly after cessation of therapy and reached normal concentrations after 6-12 months. All symptoms caused by carnitine depletion disappeared. This was achieved on a normal diet without carnitine supplementation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8257960     DOI: 10.1007/bf01880631

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  20 in total

1.  An improved and simplified radioisotopic assay for the determination of free and esterified carnitine.

Authors:  J D McGarry; D W Foster
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

2.  Carnitine deficiency induced by pivampicillin and pivmecillinam therapy.

Authors:  E Holme; J Greter; C E Jacobson; S Lindstedt; I Nordin; B Kristiansson; U Jodal
Journal:  Lancet       Date:  1989-08-26       Impact factor: 79.321

3.  Optimized kinetic method for automated determination of beta-hydroxybutyrate.

Authors:  D D Koch; D H Feldbruegge
Journal:  Clin Chem       Date:  1987-10       Impact factor: 8.327

4.  Carnitine levels in human serum in health and disease.

Authors:  T Böhmer; A Rydning; H E Solberg
Journal:  Clin Chim Acta       Date:  1974-11-20       Impact factor: 3.786

5.  Excretion of L-carnitine in man.

Authors:  G Cederblad; S Lindstedt
Journal:  Clin Chim Acta       Date:  1971-06       Impact factor: 3.786

6.  A method for the determination of carnitine in the picomole range.

Authors:  G Cederblad; S Lindstedt
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

7.  The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features.

Authors:  G Karpati; S Carpenter; A G Engel; G Watters; J Allen; S Rothman; G Klassen; O A Mamer
Journal:  Neurology       Date:  1975-01       Impact factor: 9.910

8.  Pivampicillin-promoted excretion of pivaloylcarnitine in humans.

Authors:  B Melegh; J Kerner; L L Bieber
Journal:  Biochem Pharmacol       Date:  1987-10-15       Impact factor: 5.858

9.  Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye's syndrome.

Authors:  P R Chapoy; C Angelini; W J Brown; J E Stiff; A L Shug; S D Cederbaum
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

10.  Chemical studies on vitamin BT isolation and characterization as carnitine.

Authors:  H E CARTER; P K BHATTACHARYYA; K R WEIDMAN; G FRAENKEL
Journal:  Arch Biochem Biophys       Date:  1952-07       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.